A detailed history of Colonial Trust CO / Sc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Colonial Trust CO / Sc holds 37 shares of CRL stock, worth $7,351. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37
Previous 37 -0.0%
Holding current value
$7,351
Previous $10,000 30.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$164.52 - $238.84 $4,277 - $6,209
-26 Reduced 41.27%
37 $8,000
Q3 2023

Nov 13, 2023

BUY
$194.44 - $217.61 $2,333 - $2,611
12 Added 23.53%
63 $12,000
Q2 2023

Aug 14, 2023

BUY
$183.71 - $210.25 $4,776 - $5,466
26 Added 104.0%
51 $10,000
Q1 2023

May 11, 2023

SELL
$191.89 - $259.92 $4,989 - $6,757
-26 Reduced 50.98%
25 $5,000
Q4 2022

Feb 14, 2023

BUY
$197.11 - $250.07 $10,052 - $12,753
51 New
51 $11,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Colonial Trust CO / Sc Portfolio

Follow Colonial Trust CO / Sc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Colonial Trust CO / Sc, based on Form 13F filings with the SEC.

News

Stay updated on Colonial Trust CO / Sc with notifications on news.